Kuroki, Hiroo
Anraku, Tsutomu
Kazama, Akira
Bilim, Vladimir
Tasaki, Masayuki
Schmitt, Daniel
Mazar, Andrew P.
Giles, Francis J
Ugolkov, Andrey
Tomita, Yoshihiko
Article History
Received: 1 July 2019
Accepted: 22 October 2019
First Online: 27 December 2019
Competing interests
: 9-ING-41 has been licensed to Actuate Therapeutics, Inc. Andrew Mazar and Andrey Ugolkov hold an equity interest in Actuate Therapeutics, Inc. Daniel Schmitt and Francis Giles are employees of, and hold an equity interest in, Actuate Therapeutics, Inc. Hiroo Kuroki, Tsutomu Anraku, Akira Kazama, Vladimir Bilim, Masayuki Tasaki and Yoshihiko Tomita declare no competing interests.